MYCN and neuroblastoma: The BIRC5/survivin inhibitor YM155 can inhibit USP7 deubiquitinase activity, promote the degradation of N-Myc in MNA cells, and inhibit the growth of MNA-NB in vivo (Li et al., 2023).